arrow
Back
D

David L. Rimm

department of pathology

134H-index
1.5KPaper Count
7.0WCitation Count
Published Papers 406
Publication Date
Prospective assessment of a quantitative immunofluorescent assay to measure HER2 and TROP2 concentrations on a single tissue biopsy slide
err2026-08-12
err0
errOAAI
errNay N. N. Chan; Julia Benanto; Liam Scott; Mengni He; C. Jack Robbins; Daniel C. Liebler; Regan Fulton; David L. Rimm
errShare
errSave
Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer
err2026-03-13
err0
errOAAI
errPaolo Tarantino; Se-Eun Kim; Melissa E. Hughes; Ross J. Kusmick; Kalie Smith; Fara Brasó-Maristany; Nay Nwe Nyein Chan; Laia Paré Brunet; Laura Alder; Diana Garcia-Cortes; Jorge Gomez Tejeda Zanudo; Alyssa M. Pereslete; Laura Noteware; Heather Moore; Amanda E. D. Van Swearingen; Tianyu Li; Hersh Gupta; Olivia D’Amico; Alba Martini; Stefania Morganti; Jennifer Spindel; Charmaine Cook; Christine McLaughlin; Kathrin Dvir; Ana C. Garrido-Castro; Sarah Sammons; Janet Files; Kerry Sendrick; Simone Buck; Deborah Dillon; Rinath Jeselsohn; Yvonne Y. Li; Andrew D. Cherniack; Patricia LoRusso; Maryam Lustberg; Rosario Vega- León; Francisco Pardo; Justin Davis; Claudius Mueller; Brian Corgiat; Giuseppe Curigliano; Carey K. Anders; Emanuel F. Petricoin; David L. Rimm; Aleix Prat; Nabihah Tayob; Nancy U. Lin; Sara M. Tolaney
errShare
errSave
Metabolic characterization of tumor-immune interactions by multiplexed immunofluorescence reveals spatial mechanisms of immunotherapy response in non-small cell lung carcinoma (NSCLC)
err2026-02-03
err0
errOAAI
errJames Monkman; Aaron Kilgallon; Clara Lawler; Rafael Tubelleza; Thazin Nwe Aung; Jonathan H. Warrell; Ioannis Vathiotis; Ioannis P. Trontzas; Niki Gavrielatou; Nay Nwe Nyein Chan; Rotem Czertok; Shai Bookstein; Ken O’Byrne; Ettai Markovits; David L. Rimm; Arutha Kulasinghe
errShare
errSave
STING predicts patterns of failure in locally advanced head and neck squamous cell carcinoma
err2026-01-22
err0
errOAAI
errTyler MacNeil, MD; Thomas J Hayman, MD PhD; Shengguo Li, MS; Myrto Moutafi, MD PhD MSc; Sandra Martinez-Morilla, PhD; Ioannis A Vathiotis, MD PhD MSc; Rong Hu, MD PhD; Paul M Harari, MD; Barbara Burtness, MD; Hao Liu, PhD; Randall J Kimple, MD PhD; David L Rimm, MD PhD; Joseph N Contessa, MD PhD; null
errShare
errSave
Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer
err2025-10-10
err0
errOAAI
errThazin N. Aung; James Monkman; Jonathan Warrell; Ioannis Vathiotis; Katherine M. Bates; Niki Gavrielatou; Ioannis P. Trontzas; Chin Wee Tan; Aileen I. Fernandez; Myrto Moutafi; Ken O’ Byrne; Kurt A. Schalper; Konstantinos Syrigos; Roy S. Herbst; Arutha Kulasinghe; David L. Rimm
errShare
errSave
Pathomic immune biomarkers define recurrence risk in early-stage melanoma
err2025-10-01
err0
errOAAI
errAung, Thazin Nwe; Singh, Ajay; Espinoza, Gerardo; Zhang, Chenxin; Jiang, Tianyun; Kenchappa, Divya; Bracero, Yadriel; Rakhade, Swanand; Sultana, Sharmin; Shukla, Suryansh; Nghiem, Emily; Abbruzzese, Matteo; Kuang, Chaoyuan; Geskin, Larisa; Entenberg, David; Gartrell, Robyn; Ferringer, Tammie; Leung, Lawrence; Moon, Jee-Young; Horst, Basil; Nastiuk, Kent; Rimm, David; Chang, Rui; Saenger, Yvonne
errShare
errSave
Validation and Prospective Testing of a High Sensitivity, Quantitative Analytic Assay for HER2 on Histopathology Slides
err2025-08-27
err0
PREAI
errNay N.N. Chan; Patricia Gaule; Julia Benanto; Liam Scott; Charles J. Robbins; Mengni He; Katherine Bates; Revekka Khaimova; Daniel C. Liebler; Regan Fulton; David L. Rimm
errShare
errSave
Quantitative assessment of HER2 expression in invasive ductal carcinoma and co-existing DCIS
err2025-07-18
err0
PREAI
errHaiying Zhan; Nay Nwe Nyein Chan; Revekka Khaimova; Thazin N. Aung; Patricia Gaule; Charles J. Robbins; David L. Rimm
errShare
errSave
errShare
errSave
HER2 testing: evolution and update for a companion diagnostic assay
err2025-04-07
err1
PREAI
errRobbins, Charles J.; Bates, Katherine M.; Rimm, David L.
errShare
errSave
Reading vs Measuring: Comparison of Pathologist-Based Scores to Analytic Measurements
err2025-03-01
err0
PREAI
errBates, Katherine; Fernandez, Aileen; Martinez-Morilla, Sandra; Chan, Nay Nwe Nyein; Benanto, Julia; Reisenbichler, Emily; Rimm, David
errShare
errSave
Analytical Validation and Prospective Study of a High-Sensitivity HER2 (HS-HER2) Quantitative Immunofluorescence Assay for Enhanced Stratification of HER2-Low Breast Cancer Patients
err2025-03-01
err0
PREAI
errChan, Nay Nwe Nyein; Gaule, Patricia; Benanto, Julia; Robbins, Charles; Scott, Liam; Hill, Salisha; Morrison, Ryan; Liebler, Daniel; Fulton, Regan; Rimm, David
errShare
errSave
The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?
err2024-12-01
err0
PREAI
errVidal, Joan Martinez; Tsiknakis, Nikos; Staaf, Johan; Bosch, Ana; Ehinger, Anna; Nimeus, Emma; Salgado, Roberto; Bai, Yalai; Rimm, David L.; Hartman, Johan; Acs, Balazs
errShare
errSave
Quantitative standardized high sensitivity (HS)-HER2 testing predicts outcomes with trastuzumab deruxtecan (T-DXd) for metastatic breast cancer (MBC)
err2024-09-01
err2
PREAI
errTarantino, P.; Kim, S. E.; Chan, N. N. N.; Hughes, M. E.; Smith, K.; D'Amico, O. R.; Kusmick, R.; Pereslete, A. M.; Alder, L.; Anders, C.; Morganti, S.; Garrido-Castro, A. C.; Lorusso, P.; Lustberg, M.; Sammons, S.; Lin, N.; Li, T.; Tayob, N.; Rimm, D.; Tolaney, S. M.
errShare
errSave
Quantitative Measurement of HER2 Expression in Non-Small Cell Lung Cancer With a High-Sensitivity Assay
err2024-09-01
err0
PREAI
errLiu, Matthew; Vathiotis, Ioannis; Robbins, Charles J.; Chan, Nay Nwe Nyein; Moutafi, Myrto; Burela, Sneha; Xirou, Vasiliki; Schalper, Kurt A.; Herbst, Roy S.; Syrigos, Konstantinos; Rimm, David L.
errShare
errSave
Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma
err2024-06-05
err1
PREAI
errAung, Thazin N.; Warrell, Jonathan; Martinez-Morilla, Sandra; Gavrielatou, Niki; Vathiotis, Ioannis; Yaghoobi, Vesal; Kluger, Harriet M.; Gerstein, Mark; Rimm, David L.
errShare
errSave
RNAScope: a practical approach and promising alternative to immunohistochemistry to quantify HER2 expression in breast cancer
err2024-05-02
err0
PREAI
errLi, Xiaoxian; Lee, Ji-Hoon; Gao, Yuan; Zhang, Jilun; Bates, Katherine; Rimm, David; Zhang, Huina; Smith, Geoffrey; Lawson, Diane; Meisel, Jane; Chang, Jenny; Huo, Lei
errShare
errSave
Impact of HER2 expression dynamics on the realworld activity of trastuzumab deruxtecan for metastatic breast cancer (RELIEVE)
err2024-05-02
err0
PREAI
errTarantino, Paolo; Hughes, Melissa; Kusmick, Ross; Alder, Laura; Pereslete, Alyssa; Noteware, Laura; Moore, Heather; Van Swearingen, Amanda; Li, Tianyu; Gupta, Hersh; Smith, Kalie; Morganti, Stefania; Files, Janet; Sendrick, Kerry; Buck, Simone; Dillon, Deborah; Jeselsohn, Rinath; Li, Yvonne; Cherniack, Andrew; Prat, Aleix; Chan, Nay Nwe Nyein; Rimm, David; Curigliano, Giuseppe; Sammons, Sarah; Anders, Carey; Lin, Nancy; Tolaney, Sara
errShare
errSave